Advanced AI tools have emerged to dissect intratumoral heterogeneity with precision, potentially transforming cancer treatment personalization. Meanwhile, CAR-T cell therapy advances confront tumor microenvironment challenges through engineered constructs improving specificity and resistance to immune suppression. Additionally, immune cell therapies demonstrate promise by enhancing survival rates in colorectal cancer patients, marking a paradigm shift in oncologic immunotherapy.